Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment

Abstract Assisted reproductive technology (ART) treatment accounted for 6% of total births in 2017 and is increasing which places Japan among the top worldwide in number of treatments performed. Although ART treatment patients often experience heavy physical and psychological burden, few epidemiolog...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tsuguhiko Kato, Makiko Sampei, Kazuki Saito, Naho Morisaki, Kevin Y. Urayama
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1b990129979f4c31b9d134bc69ed2abd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1b990129979f4c31b9d134bc69ed2abd
record_format dspace
spelling oai:doaj.org-article:1b990129979f4c31b9d134bc69ed2abd2021-12-02T14:20:34ZDepressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment10.1038/s41598-021-87057-62045-2322https://doaj.org/article/1b990129979f4c31b9d134bc69ed2abd2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87057-6https://doaj.org/toc/2045-2322Abstract Assisted reproductive technology (ART) treatment accounted for 6% of total births in 2017 and is increasing which places Japan among the top worldwide in number of treatments performed. Although ART treatment patients often experience heavy physical and psychological burden, few epidemiologic studies have been conducted in Japan. We examined mental health and health-related quality of life (QOL) among women at early stages of treatment. We recruited 513 women who have initiated ART treatment, either in-vitro fertilization or intracytoplasmic sperm injection, from four medical facilities in the Tokyo area and through web-based approaches. At baseline, we collected socio-demographic information and assessed depressive symptoms, anxiety, and QOL. Descriptive analyses were performed overall and stratified by factors such as age. Mild depressive symptoms or worse, assessed with Quick Inventory of Depressive Symptoms, were observed among 54% of participants. Mean score for State-Trait Anxiety Inventory was 52 with a standard deviation of 11 for the state, and 39% were categorized as high anxiety. QOL results, assessed with SF-12, showed the same negative tendency for social functioning and role (emotional), while general health and physical functioning were consistent with the national average. Young participants appeared to suffer mentally more than older participants (p < 0.01 for depressive symptoms). Our findings suggest that patients may be at high risk of depressive symptoms, high anxiety, and low QOL even from the early stages of ART treatment.Tsuguhiko KatoMakiko SampeiKazuki SaitoNaho MorisakiKevin Y. UrayamaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tsuguhiko Kato
Makiko Sampei
Kazuki Saito
Naho Morisaki
Kevin Y. Urayama
Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment
description Abstract Assisted reproductive technology (ART) treatment accounted for 6% of total births in 2017 and is increasing which places Japan among the top worldwide in number of treatments performed. Although ART treatment patients often experience heavy physical and psychological burden, few epidemiologic studies have been conducted in Japan. We examined mental health and health-related quality of life (QOL) among women at early stages of treatment. We recruited 513 women who have initiated ART treatment, either in-vitro fertilization or intracytoplasmic sperm injection, from four medical facilities in the Tokyo area and through web-based approaches. At baseline, we collected socio-demographic information and assessed depressive symptoms, anxiety, and QOL. Descriptive analyses were performed overall and stratified by factors such as age. Mild depressive symptoms or worse, assessed with Quick Inventory of Depressive Symptoms, were observed among 54% of participants. Mean score for State-Trait Anxiety Inventory was 52 with a standard deviation of 11 for the state, and 39% were categorized as high anxiety. QOL results, assessed with SF-12, showed the same negative tendency for social functioning and role (emotional), while general health and physical functioning were consistent with the national average. Young participants appeared to suffer mentally more than older participants (p < 0.01 for depressive symptoms). Our findings suggest that patients may be at high risk of depressive symptoms, high anxiety, and low QOL even from the early stages of ART treatment.
format article
author Tsuguhiko Kato
Makiko Sampei
Kazuki Saito
Naho Morisaki
Kevin Y. Urayama
author_facet Tsuguhiko Kato
Makiko Sampei
Kazuki Saito
Naho Morisaki
Kevin Y. Urayama
author_sort Tsuguhiko Kato
title Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment
title_short Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment
title_full Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment
title_fullStr Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment
title_full_unstemmed Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment
title_sort depressive symptoms, anxiety, and quality of life of japanese women at initiation of art treatment
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1b990129979f4c31b9d134bc69ed2abd
work_keys_str_mv AT tsuguhikokato depressivesymptomsanxietyandqualityoflifeofjapanesewomenatinitiationofarttreatment
AT makikosampei depressivesymptomsanxietyandqualityoflifeofjapanesewomenatinitiationofarttreatment
AT kazukisaito depressivesymptomsanxietyandqualityoflifeofjapanesewomenatinitiationofarttreatment
AT nahomorisaki depressivesymptomsanxietyandqualityoflifeofjapanesewomenatinitiationofarttreatment
AT kevinyurayama depressivesymptomsanxietyandqualityoflifeofjapanesewomenatinitiationofarttreatment
_version_ 1718391534048509952